Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
出版年份 2021 全文链接
标题
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
作者
关键词
-
出版物
Neurotherapeutics
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-12-03
DOI
10.1007/s13311-021-01165-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis
- (2021) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Comparison of sixteen serological SARS-CoV-2 immunoassays in sixteen clinical laboratories
- (2021) Lene H. Harritshøj et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Willingness to be vaccinated against COVID-19: an exploratory online survey in a Portuguese cohort of multiple sclerosis patients
- (2021) Filipa Serrazina et al. Multiple Sclerosis and Related Disorders
- COVID-19 Vaccine Failure in a Patient with Multiple Sclerosis on Ocrelizumab
- (2021) Sridhar Chilimuri et al. Vaccines
- Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
- (2021) Diego Centonze et al. JOURNAL OF NEUROLOGY
- COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
- (2021) Anat Achiron et al. Multiple Sclerosis Journal
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States
- (2021) Dawn M. Ehde et al. Multiple Sclerosis and Related Disorders
- Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel
- (2021) Itay Lotan et al. EUROPEAN JOURNAL OF NEUROLOGY
- Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report
- (2021) Jessica Ferguson et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre‐pandemic controls
- (2021) Kiwook Jung et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients
- (2021) Hannah Kelly et al. JOURNAL OF NEUROIMMUNOLOGY
- Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience
- (2021) Guerrieri S. et al. JOURNAL OF NEUROLOGY
- Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
- (2021) Antonio Gallo et al. NEUROLOGICAL SCIENCES
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
- (2021) Nassim Kamar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection
- (2021) K. Bigaut et al. REVUE NEUROLOGIQUE
- COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab
- (2021) Fabio Buttari et al. Multiple Sclerosis and Related Disorders
- HUMORAL RESPONSE TO SARS-CoV-2 AND COVID-19 VACCINES IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH IMMUNE RECONSTITUTION THERAPIES
- (2021) Jelena Drulovic et al. Multiple Sclerosis and Related Disorders
- DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France
- (2021) Maria Pia Sormani et al. Annals of Clinical and Translational Neurology
- Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19
- (2021) Leoni Rolfes et al. Neurology-Neuroimmunology & Neuroinflammation
- Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study
- (2020) Amit Bar-Or et al. NEUROLOGY
- SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
- (2020) Christopher O. Barnes et al. NATURE
- Effects of MS disease-modifying therapies on responses to vaccinations: A review.
- (2020) John Robert Ciotti et al. Multiple Sclerosis and Related Disorders
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
- (2020) Sara E. Oliver et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started